Chemokines are secreted proteins that regulate cell migration and are involved in inflammatory and immune responses. Here, we sought to define the functional crosstalk between the lipid signaling and chemokine signaling. We obtained evidence that the induction of some chemokines is regulated by group VIA calcium-independent phospholipase A 2 b (iPLA 2 b) in IL-1b-stimulated rat fibroblastic 3Y1 cells. Treatment of 3Y1 cells with IL-1b elicited an increased release of chemotactic factor(s) for monocytic THP-1 cells into culture medium in a time-dependent manner. Inhibitor studies revealed that an intracellular PLA 2 inhibitor, arachidonoyl trifluoromethyl ketone (AACOCF 3 ), but not the cyclooxygenase inhibitor indomethacin, attenuated the release of chemotactic factor(s). The chemotactic activity was inactivated by treatment with either heat or proteinase K, suggesting this chemotactic factor(s) is a proteinaceous factor(s). We purified the chemotactic factor(s) from the conditioned medium of IL-1b-stimulated 3Y1 cells using a heparin column and identified several chemokines, including CCL2 and CXCL10. The inducible expressions of CCL2 and CXCL10 were significantly attenuated by pretreatment with AACOCF 3 . Gene silencing using siRNA revealed that the inductions of CCL2 and CXCL10 were attenuated by iPLA 2 b knockdown. Additionally, the transcriptional activation of nuclear factor of activated T-cell proteins (NFATs), but not nuclear factorjB, by IL-1b stimulation was markedly attenuated by the iPLA 2 inhibitor bromoenol lactone, and NFATc4 knockdown markedly attenuated the IL-1b-induced expression of both CCL2 and CXCL10. Collectively, these results indicated that iPLA 2 b plays roles in IL-1b-induced chemokine expression, in part via NFATc4 signaling.
Introduction
The migration of leukocytes to inflamed sites is a critical step in the host's defense against various pathogens, and it is regulated by a variety of chemoattractants, including lipid (leukotriene B 4 and lysophosphatidic acid) and proteinous mediators (chemokines) [1] [2] [3] . The productions of these lipid mediators are regulated by the phospholipase A 2 (PLA 2 ) 3 pathway, whereas the productions of chemokines are controlled by the transcriptional activation of several transcriptional factors [4] [5] [6] . It has been shown that the activation of nuclear factor-jB (NF-jB) by a cytokine or by exogenous pathogens is one of the master regulators of the induction of chemokine expression, and that this activation is involved in the interleukin-1b (IL-1b)-stimulated inductions of CCL2 (C-C motif ligand 2)/MCP-1 (monocyte chemoattractant protein-1), CXCL1 (C-X-C motif ligand 1)/KC (keratinocyte-derived chemokine), and CXCL10 (C-X-C motif ligand 10)/IP-10 (interferonc-inducible protein-10) in several cells [5, 7, 8] .
It was also shown that other transcription factors such as nuclear factor of activated T-cell proteins (NFATs) participate in the inductions of CCL2 and CXCL10 in cytokine-stimulated human retinal microvascular endothelial cells [6] . Thus, the signaling pathways that induce each chemokine are diverse, and they depend on the cell type and stimulus. Although the molecular mechanisms leading to the transcriptional activation of NF-jB following cytokine stimulation have been well-studied, little is known about the upstream machinery that leads to the activation of NFAT following cytokine stimulation.
PLA 2 s are a family of enzymes that hydrolyze the ester bond at the sn-2 position of membrane glycerophospholipids to generate free fatty acids and lysophospholipids, both of which are precursors of many types of bioactive lipid mediators [9] [10] [11] . More than 20 PLA 2 enzymes have been identified in mammals and they are divided into four groups according to their enzymatic properties: the cytosolic PLA 2 (cPLA 2 ), Ca 2+ -independent PLA 2 (iPLA 2 ), secreted PLA 2 (sPLA 2 ), and lipoprotein-associated PLA 2 enzymes. Among the members of the PLA 2 family, the cPLA 2 (Group IV PLA 2 ) and iPLA 2 (Group VI PLA 2 ) enzymes are intracellular PLA 2 enzymes with a catalytic serine in their lipase consensus motif. The existence of diverse PLA 2 enzymes and the differences in their enzymatic properties suggest that each PLA 2 enzyme exerts unique biological activities through the degradation of lipids.
Although several lines of evidence indicate that the intracellular PLA 2 pathway participates in proinflammatory gene induction in cultured cells and animal models [12] [13] [14] [15] [16] , the mechanisms leading to the inductions of such genes are not fully understood. Among these genes, we previously found that the group IIA sPLA 2 (PLA2G2A) is under the control of a group VIB iPLA 2 c in cytokinetreated rat fibroblastic 3Y1 cells [12, 17] . In addition, in the case of transforming growth factor-a and IL-1b-treated rat gastric mucosal cells [15] and tumor necrosis factor a (TNFa) and sPLA 2 -treated rat mesangial cells [14] , group IVA cPLA 2 a participated in the induction of PLA2G2A. These results led us to the notion that a prior activation of intracellular PLA 2 s is required for the de novo induction of PLA2G2A expression.
Previous works have revealed that PLA2G2A, the sPLA 2 isozyme found in various inflamed sites [18] and upregulated during inflammation [19] [20] [21] , exerts potent bactericidal activity against several bacteria [22] [23] [24] through the degradation of bacterial phospholipids to protect the host from exogenous pathogens. In addition to bacterial phospholipids, PLA2G2A can hydrolyze the extracellular vesicles and mitochondria derived from activated platelets and facilitates inflammation [25, 26] . Thus, the intracellular PLA 2 pathways seem to be involved in the expression of genes associated with inflammatory responses; however, it remains unclear which genes other than PLA2G2A are regulated by intracellular PLA 2 s and how intracellular PLA 2 s transmit their signaling pathways following cytokine stimulation. To address these issues, we here attempted to determine such targets and the signaling pathway in IL-1b-treated rat fibroblasts by using a cell-based assay, a proteomics analysis, and biochemical/genetic approaches.
Results
Detection and characterization of chemotactic factor(s) released from IL-1b-stimulated 3Y1 cells
We previously reported that the IL-1b stimulation of rat fibroblastic 3Y1 cells elicits several inflammatory responses, such as the release of eicosanoids and the induction of group IIA sPLA 2 s, in a manner dependent on the intracellular PLA 2 s [12, 17] . To expand our understanding of these findings, we herein attempted to identify chemotactic factors regulated by the action of PLA 2 s. In a cell migration assay, we used human monocytic THP-1 cells to screen the release of chemotactic factors from IL-1b-treated 3Y1 cells, because previous results revealed that THP-1 cells have the ability to migrate toward various chemotactic factors, such as chemokines and lipid mediators [27] [28] [29] . When 3Y1 cells were stimulated with IL-1b, the chemotactic activity in the conditioned medium was increased over 6-24 h of stimulation (Fig. 1A) . We next examined the effect of pertussis toxin (PTX) on THP-1 cell migration because it has been shown that Gai-proteincoupled receptors have a mediatory role in chemotactic processes [30] [31] [32] . As shown in Fig. 1B , the pretreatment of THP-1 cells with 100 ngÁmL À1 PTX significantly attenuated their migratory activity. These results suggest that stimulation of 3Y1 cells with IL-1b elicits the marked release of a chemotactic factor or factors that activate Gai-protein signaling in THP-1 cells.
Because various factors such as lipids, nucleotides, and proteins have been shown to have chemotactic activity [29, 33, 34] , we next sought to characterize the 3Y1 cell-derived chemotactic factor(s). As shown in Fig. 2A ,B, the chemotactic activities were significantly attenuated by treatment of the conditioned medium with heat or proteinase K. By contrast, treatment of the conditioned medium with the ATP-hydrolyzing enzyme apyrase failed to suppress the chemotactic activity, although the ATP-dependent THP-1 cell migration was markedly suppressed (Fig. 2C) .
We next examined the effect of various inhibitors on the IL-1b-induced release of the chemotactic factor(s). The culture of 3Y1 cells with IL-1b for 24 h in the presence of the protein synthesis inhibitor cycloheximide (CHX) significantly attenuated their release (Fig. 3A) . These results suggest that the chemotactic factor(s) released from the IL-1b-treated 3Y1 cells consisted mainly of a proteinaceous factor such as a chemokine. We also found that the anti-inflammatory glucocorticoid dexamethasone (DEX) did not affect the release of the chemotactic factor(s) from 3Y1 cells (Fig. 3A) .
Several reports have shown that intracellular PLA 2 contributes to the inducible expression of secreted PLA 2 s following proinflammatory stimuli [12] [13] [14] [15] . From these observations, we hypothesized that the release or induction of our target chemotactic factor(s) would also be regulated by the intracellular PLA 2 pathway and examined the effects of arachidonyl trifluoromethyl ketone (AACOCF 3 ), an intracellular PLA 2 inhibitor [35, 36] , on the IL-1b-stimulated release of chemotactic factor(s). As shown in Fig. 3B , the IL-1b-stimulated release of the chemotactic factor(s) was partially reduced by treatment with AACOCF 3 , suggesting that the activation of the PLA 2 pathway following IL-1b treatment contributed to the release or induction of the chemotactic factor(s). Indomethacin, a nonselective cyclooxygenase (COX) inhibitor, did not affect the IL-1b-induced release of chemotactic factor(s), indicating that this event is independent of endogenous prostaglandins.
Because previous studies have shown that the intracellular PLA 2 s (cPLA 2 a, iPLA 2 b and iPLA 2 c) expressed in migrating cells contribute to their migratory function [29, 37] , we next examined whether AACOCF 3 directly attenuates the migration of THP-1 cells toward the conditioned medium obtained from IL-1b-treated 3Y1 cells. As shown in Fig. 3C , the migration of THP-1 cells toward the IL-1b-treated conditioned medium was not affected by the addition of AACOCF 3 , suggesting that the inhibitory effect of AACOCF 3 on the migration of THP-1 cells is the result of its attenuating the release or induction of a chemotactic factor, rather than a direct inhibition of intracellular PLA 2 in THP-1 cells. Fig 
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Purification of the chemotactic factor(s) through HiTrapTM heparin chromatography
We next conducted a proteomic analysis of the conditioned medium of IL-1b-treated 3Y1 cells to find chemokines. To purify the chemokines, we used heparin column chromatography, because an earlier study showed that several chemokines could bind to a heparin column [38] . When we applied the conditioned medium obtained from IL-1b-stimulated 3Y1 cells to HiTrapTM heparin column chromatography, a single major peak of chemotactic activity was eluted with approx. 0.5 M NaCl (Fig. 4A ). Because approx. 90% of the chemotactic activity was trapped by the heparin column and nearly 80% of the chemotactic activity was recovered in the NaCl-eluted fractions ( Fig. 4B ), we speculated that the proteinaceous chemotactic factor released from IL-1b-treated 3Y1 cells was a chemokine. To investigate this possibility, we trypsinized the heparin column-binding fractions, and analyzed the peptide sequences by nano-LC-MS/MS. The LC-MS/MS analysis revealed that there were nearly 50 proteins, including four chemokines (CXCL1, CCL2, CXCL10, and CXCL2), in the heparin column-binding fractions. The peptide sequences of the chemokines identified with high confidence are listed in Table 1 .
In this proteomics analysis, we could detect only one peptide of CXCL2 chemokine with a coverage of less than 10%, which was not sufficient to prove the presence of this chemokine. Thus, further investigation was required for the identification of these four chemokines. Next, therefore we conducted an immunoblot analysis with specific antibodies against these chemokines. As shown in Fig. 4C , all the identified chemokines except for CXCL2 could be detected by immunoblotting, and they were almost completely bound to the heparin column and eluted between fraction 4 and fraction 6. These chemokines were faintly detected in the conditioned medium obtained from unstimulated 3Y1 cells (Fig. 4D) . Interestingly, the elution profile of CCL2 corresponded to the profile of chemotactic activity (Fig. 4A,C) . In addition, the anti-CCL2 antibody -but not the anti-CXCL1 or anti-CXCL10 antibody -neutralized the chemotactic activity released from IL-1b-treated 3Y1 cells (Fig. 4E) , suggesting that CCL2 is the main contributor to the migration of THP-1 cells under these conditions.
Regulation of the chemokine induction by group VIA iPLA 2 b in rat fibroblasts
We next examined whether the intracellular PLA 2 inhibitor AACOCF 3 affects the IL-1b-induced expressions of CCL2, CXCL1, and CXCL10. When 3Y1 cells were stimulated with IL-1b for 24 h, the mRNA expressions of CCL2, CXCL1, and CXCL10 were significantly upregulated compared to the unstimulated control (Fig. 5A) . Interestingly, we observed that AACOCF 3 markedly suppressed the mRNA expressions of CCL2 and CXCL10, and partially suppressed that of CXCL1 ( Prior to the THP-1 cell migration assay, the culture medium from IL-1b-treated 3Y1 cells was pretreated with antibodies against chemokines, and then the chemotactic activity was assessed. All antibodies were used at a concentration of 5 lgÁmL
À1
. Data are means AE SDs from three individual experiments. *P < 0.05. chemokines released into the culture medium following IL-1b stimulation were also suppressed by AACOCF 3 (Fig. 5B) . These results suggest that activation of the intracellular PLA 2 pathway after IL-1b treatment is crucial for the subsequent induction of these chemokines in 3Y1 cells.
Since AACOCF 3 is able to inhibit several intracellular PLA 2 enzymes [12] , we next investigated which PLA 2 isozyme(s) is involved in the regulation of IL1b-induced chemokine expression. As shown in Fig. 5C , the treatment of 3Y1 cells with the siRNA against each PLA 2 specifically reduced the expression levels of each PLA 2 protein without affecting other related isoforms. Immunoblot analysis revealed that the induction of CCL2 and CXCL10, but not CXCL1, was markedly attenuated by the knockdown of iPLA 2 b (Fig. 5D ), suggesting the iPLA 2 b pathway regulates the expression of CCL2 and CXCL10. Although the actual mechanism of the induction of CXCL1 remains unknown, it appears to be regulated by other intracellular PLA 2 or AACOCF 3 -sensitive enzyme(s). To our knowledge, our results provide the first evidence of a relationship between the intracellular PLA 2 signaling pathway and chemokine induction, although a relationship between cell migration and the intracellular PLA 2 pathway has been shown previously [29, 39, 40] . Because lysophosphatidic acid is involved in the iPLA 2 b signaling pathway [29, 40] , we explored the effects of the lysophosphatidic acid antagonist Ki16425 on the inducible expression of CCL2 and CXCL10 in IL-1b-treated 3Y1 cells. As shown in Fig. 5E , Ki16425 failed to affect the IL-1b-induced expression of CCL2 and CXCL10 (Fig. 5E ).
NFATc4 regulates the IL-1b-dependent CCL2 and CXCL10 expressions via the iPLA 2 b pathway in rat fibroblasts
To define the signaling pathway of the chemokine expression mediated by the iPLA 2 b pathway, we next evaluated the effect of a PLA 2 inhibitor on the activation of transcription factors following IL-1b (Fig. 6A) . However, the NF-jB activation following IL-1b stimulation was minimally affected by treatment with AACOCF 3 or the iPLA 2 inhibitor bromoenol lactone (BEL) (Fig. 6A) , suggesting that the PLA 2 pathway was not involved in the IL-1b-dependent NF-jB activation. NFATs are transcription factors that regulate the expression of various proinflammatory genes, including chemokines [6, 42, 43] . We next investigated the roles of NFATs in intracellular PLA 2 -dependent chemokine induction. As shown in Fig. 6B , the stimulation of NFAT reporter-expressing 3Y1 cells with IL-1b for 6 h markedly increased the NFAT reporter activity compared to that in unstimulated control cells, and this activity was significantly attenuated by treatment with AACOCF 3 or BEL. These results suggested that in 3Y1 cells, activation of NFAT following IL-1b stimulation is under the control of the iPLA 2 pathway.
Because five NFAT isoforms have been identified in mammals, we next examined which NFAT isoform plays a role in the regulation of IL-1b-dependent chemokine expression in 3Y1 cells. In the real-time RT-PCR analysis, mRNAs for NFATc3, NFATc4 and NFAT5 were detected at high levels in 3Y1 cells, whereas those of NFATc1 and NFATc2 were detected at low levels (Fig. 7A) . We also observed the expressions of NFATc3, NFATc4, and NFAT5 proteins, but not those of NFATc1 and NFATc2, in 3Y1 cells ( protein expression were strongly induced by the treatment of 3Y1 cells with IL-1b for 24 h (Fig. 7A,B) . We next examined whether the knockdown of NFAT isoforms affects the expression of chemokines in IL-1b-treated 3Y1 cells. The efficacy of each siRNA was assessed by immunoblotting, and the siRNA treatment resulted in a marked reduction in each NFAT in comparison with those in control cells (Fig. 7C,D) . As shown in Fig. 7E , the IL-1b-induced CCL2 and CXCL10 expressions were markedly attenuated by the knockdown of NFATc4. In contrast to the expressions of these chemokines, the expression of CXCL1 was not attenuated by the knockdown of NFATc4 (Fig. 7E) . The knockdowns of NFATc3 and NFAT5 were unable to suppress the induction of these chemokine expressions in IL-1b-treated 3Y1 cells (Fig. 7E) . Even though the activating pathway of NFATc4 in 3Y1 cells is currently unknown, the activation of NFATc4 after IL-1b stimulation is critical for the induction of CCL2 and CXCL10 expression in these cells. Based on our present results, we concluded that the iPLA 2 b-NFATc4 axis plays a crucial role in the IL-1b-dependent induction of several chemokines. Our findings are consistent with an earlier report that NFATc4 regulates the induction of several chemokines, including CCL2 and CXCL10, in TNFa-treated human retinal microvascular endothelial cells [6] . Although the signaling pathway leading to the chemokines following TNFa stimulation is unclear, it would be of interest to examine whether the iPLA 2 b pathway or another intracellular PLA 2 pathway is involved in the regulation of chemokine expression in these cells.
Discussion
We and others have shown that the expression of stimulus-dependent sPLA 2 s is under the control of the intracellular PLA 2 s pathway. In the case of 3Y1 fibroblasts, iPLA 2 c participates in the inducible expression of group IIA sPLA 2 following IL-1b stimulation [12] . In other cases, cPLA 2 a is involved in the induction of sPLA 2 -IIA in rat gastric epithelial cells and rat mesangial cells [14, 15] . In the present study, we investigated whether there are additional proteins that are regulated by the intracellular PLA 2 pathway following proinflammatory stimulation, and our results provide new insights into the regulatory mechanisms of this intracellular PLA 2 -mediated gene expression. Because group IIA sPLA 2 is a prototypic proinflammatory sPLA 2 , we hypothesized that the intracellular PLA 2 -regulatory genes might be related to inflammation. In an effort to identify new intracellular PLA 2 -regulatory molecules, we used proteomic approaches to identify the candidate(s) for intracellular PLA 2 -regulated genes in IL-1b-stimulated fibroblasts. To find such factor(s), we focused on the chemotaxis of monocytes, a major event in inflammatory responses, and found that several chemokines, such as CCL2 and CXCL10, are under the control of the iPLA 2 b pathway. In addition, our analysis revealed that NFATc4 was required for the IL-1b-induced expression of CCL2 and CXCL10 in these cells. Thus, we concluded that the iPLA 2 bNFATc4 axis has a crucial role in the IL-1b-dependent induction of several chemokines. glycerophospholipids to produce free fatty acids and lysophospholipids [44, 45] . In addition to its PLA 2 activity, iPLA 2 b can exert various enzymatic activities, such as PLA 1 , lysophospholipase, transacylase, and thioesterase activities [46, 47] . Thus, iPLA 2 b might act by producing lipid product(s), such as fatty acids (or their metabolites) and lysophospholipids (1-or 2-acyl lysophospholipids), to serve its diverse functions. We hypothesized that IL-1b-induced expression of CCL2 and CXCL10 is regulated via certain iPLA 2 b-derived lipid(s). Indeed, it has been suggested that iPLA 2 bderived lysophosphatidic acid participates in the macrophage migration toward CCL2 by autocrine mechanisms [29, 40] . However, it seems unlikely that iPLA 2 b-derived lysophosphatidic acid was involved in the signaling pathway for induction of CCL2 and CXCL10 in our system, because the lysophosphatidic acid antagonist Ki16425 failed to affect the IL-1b-induced expression of CCL2 and CXCL10 (Fig. 5E ). In addition, several lines of data indicate that neither the COX nor the 5-lipoxygenase pathway is involved in chemokine induction. First, treatment of 3Y1 cells with the nonselective COX inhibitor indomethacin failed to attenuate the IL-1b-induced release of chemotactic factor(s) in the present study (Fig. 3) . Second, 3Y1 cells do not express 5-lipoxygenase [48, 49] , and indeed could not produce 5-lipoxygenase products, such as leukotriene B 4 , following IL-1b stimulation in our experiments (data not shown). By contrast, it has been shown that several lipids of the iPLA 2 b-12/15-lipoxygenase pathway contribute to the expression of several proinflammatory genes, such as CCL2, in vascular smooth muscle cells in an NF-jB or a cAMP-response element-binding protein-dependent manner [50] [51] [52] [53] . Our previous studies revealed that IL-1b-induced group IIA sPLA 2 expression is under the control of certain product(s) of the iPLA 2 c-12/15-lipoxygenase pathway in 3Y1 cells [12, 54] . Thus, we speculate that the product(s) of the iPLA 2 b-12/15-LOX pathway regulates IL-1b-induced CCL2 and CXCL10 induction. CCL2 and CXCL10 are chemokines that contribute to the migration of leukocytes (including monocytes/ macrophages) to inflamed sites, and they participate in various pathophysiological events. In particular, CCL2 plays a role in the infiltration of macrophages to the adipose tissue, which was shown to be an important step in the development of insulin resistance and hepatic steatosis in a murine obesity model (leptin-deficient ob/ob mice and high-fat feeding mice) [55] . Interestingly, it has been shown that iPLA 2 b also contributes to obesity and hepatic steatosis in ob/ob mice [56] . Thus, in such situations, CCL2 may work together with iPLA 2 b to worsen lifestyle-related diseases, such as obesity.
Chemotaxis is involved in various pathological events, such as inflammatory responses and atherosclerosis [55, [57] [58] [59] , as well as obesity. Thus, the control of these events may be of therapeutic benefit. Our present findings provide novel insights into the molecular mechanisms of PLA 2 -mediated monocyte chemotaxis. We showed here that the induction of CCL2 and CXCL10 in response to IL-1b stimulation is, at least in part, under the control of the iPLA 2 b-NFATc4 axis. These and our previous findings support the notion that intracellular PLA 2 s such as iPLA 2 b and iPLA 2 c may be intermediates of cytokine signaling, and that the inhibition of these intracellular PLA 2 pathways might offer a new approach for treating several diseases associated with chemokine production. To fully understand these signaling pathways, the next challenge will include identification of the lipids that are produced by the intracellular PLA 2 s and determination of the signaling pathway for activation of NFATc4 by intracellular PLA 2 product(s).
Experimental procedures
Materials
Mouse and human IL-1b, goat polyclonal anti-mouse CCL2, rat CXCL1, rat CXCL2, and mouse CXCL10 antibodies were purchased from R&D Systems (Minneapolis, MN, USA). Dexamethasone and CHX were obtained from Wako Pure Chemicals (Osaka, Japan). PTX, indomethacin, and oligonucleotide primers were purchased from Sigma (St. Louis, MO, USA). Apyrase was purchased from New England Biolabs (Beverly, MA, USA). Arachidonoyl trifluoromethyl ketone was purchased from Cayman Chemical (Ann Arbor, MI, USA). OPTI-MEM Ò medium and hygromycin B were obtained from Thermo Fisher Scientific (Waltham, MA, USA). Lipofectamine Ò 2000 and Lipofectamine
Ò
RNAiMAX reagents were purchased from Invitrogen (Carlsbad, CA, USA). NFAT-luciferase reporter vector containing 39 NFAT responsive elements (pGL4.30) was purchased from Promega (Madison, WI, USA). NF-jB-luciferase reporter vector containing 39 NF-jB responsive elements was prepared as described previously [60] . pRNA-U6.1/Hygro vector was purchased from GenScript (Piscataway, NJ, USA).
Cell culture and treatment
The conditions used for the maintenance of rat fibroblastic 3Y1 cells were as described previously [49] . The media of these cells that had attained 80% confluence in 12-well plates were replaced with 0. 
Cell migration assay
Human monocytic THP-1 cells were maintained as described previously [61] . THP-1 cell migration was analyzed in 24-well plates containing 8-lm pore-size cell culture inserts (Falcon Purification of chemotactic factor(s) from conditioned medium of IL-1b-stimulated 3Y1 cells
All of the following chromatographic steps were carried out using an AKTA Prime plus liquid chromatography system (GE Healthcare, Buckinghamshire, UK). The conditioned medium obtained from IL-1b-treated 3Y1 cells (20 mL) was injected at a flow rate of 1.0 mLÁmin À1 into a 1-mL HiTrapTM heparin column (GE Healthcare) equilibrated in buffer A (10 mM Tris-HCl, pH 6.8). After the resin was washed with buffer A for 10 min, bound proteins were eluted with a linear gradient of buffer A to 100% buffer B (10 mM Tris-HCl, pH 6.8, 2 M NaCl) over 10 min at the flow rate of 1.0 mLÁmin
À1
. The chemotactic activities eluted in each fraction were assessed by a cell migration assay as described above.
Digestion of heparin column-bound proteins by trypsin
Proteins were precipitated from heparin column-bound fractions containing chemotactic activity by trichloroacetic acid (TCA) precipitation. Briefly, proteins were precipitated in 10% TCA for 30 min on ice, then pelleted at 20 000 g for 10 min at 4°C. Pellets were washed twice with acetone. The samples were subjected to protein reduction (10 mM DTT, 45 min at room temperature) and alkylation (37 mM iodoacetamide, 45 min at room temperature). The remaining iodoacetamide was removed by adding DTT solution (40 mM DTT). Then, the samples were trypsinized (10 lgÁmL À1 trypsin, overnight at 37°C). The obtained peptide mixture was purified with a Sep-Pak Ò Light C18 Cartridge (Waters, Milford, MA, USA) prior to nano-liquid chromatographytandem mass spectrometry (LC-MS/MS) analysis.
Identification of chemotactic factors by nano-LC-MS/MS
The heparin column-bound fractions, which contained the chemotactic activities, were analyzed by nano-LC-MS/MS with the use of a DiNa nano LC system (Kya Technologies, Tokyo, Japan) coupled to a high-speed TripleTOF 5600 mass spectrometer (Sciex, Concord, ON, Canada). A capillary LC column [ESI column, 3-lm particle size, 0.1 mm i.d. 9 100 mm (E03-100-100); Kya Technologies] was used for the LC separation of peptides. Samples were first loaded onto a trap column [nano LC trap column, 0.5 mm i.d. 9 1 mm (A03-05-001); Kya Technologies] from an autosampler. After the samples were washed with 0.1% formic acid in high-performance liquid chromatography-grade water, the system was switched into line with the reverse-phase analytical capillary column. The tryptic digest was analyzed with a 40 min 3-step gradient (acetonitrile in 0.1% formic acid from 2% to 13% over 2 min, 13% to 20% over 13 min, and 20% to 80% over 5 min, followed by holding at 80% for 10 min) at the flow rate of 300 nLÁmin À1 . The settings of the TripleTOF 5600 mass spectrometer were as follows: ionspray voltage 2300 V, curtain gas 20 arbitrary units, interface heater temperature 150°C, ion source gas 1 20 arbitrary units, declustering potential 80 V. All data were acquired using the information-dependent acquisition mode with ANALYST TF 1.5.1 software (Sciex). We used PROTEINPILOT software version 4.5 (Sciex) to analyze the data obtained from the nano-LC-MS/ MS. The identified chemokines are listed in Table 1 .
Immunoblot analysis
Culture media were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS/PAGE) using 15% (w/v) gels under reducing conditions. The separated proteins were electroblotted onto nitrocellulose membranes (Schleicher & Schuell Bioscience, Dassel, Germany) with a bath-type blotter. After blocking for 1 h with 5% (w/v) skim milk in PBS containing 0.05% (v/v) Tween 20 (TPBS), the membranes were probed for 1 h with the respective antibodies (1 : 1000), followed by incubation with horseradish peroxidase-conjugated anti-goat IgG (1 : 5000). After washing, the membranes were visualized with Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life Sciences, Wellesley, MA, USA).
Quantitative real-time PCR
RNA extraction, cDNA synthesis, and SYBR green quantitative PCR (qPCR) were carried out according to standard protocols in our laboratory, as described previously [62] . The primers listed in Table S1 were used. 18S ribosomal RNA was used as the internal control for the real-time PCR.
Establishment of cell lines expressing NF-jB-or NFAT-reporter gene, and the luciferase assay
To assess the activation of NF-jB or NFAT following IL1b stimulation, we established stable 3Y1 transfectants introducing NF-jB-or NFAT-reporter plasmids. The NFAT-luciferase reporter plasmid alone, or the NF-jBluciferase reporter vector plus pRNA-U6.1/Hygro plasmids were transfected into 3Y1 cells with Lipofectamine Ò 2000
according to the manufacturer's instructions. Two days after transfection, the cells were seeded into 96-well plates in the presence of 100 lgÁmL À1 hygromycin to establish stable transfectants. The expression of reporter gene in the obtained transfectants was assessed by the detection of luciferase activity. The luciferase activity was assessed by standard protocols, as described previously [63] .
Statistical analysis
Results are expressed as the means AE standard deviation (SD). Comparisons between two groups were made with an unpaired Student's t-test, and comparisons among three or more groups were made with a two-way analysis of variance (ANOVA) and post hoc Tukey-Kramer tests. P-values of < 0.05 were considered significant.
